You just read:

Capital Pro-Égaux Inc., through its wholly owned subsidiary technique d'usinage Sinlab Inc, has received the Germany court decision on the nullity action filed by Nobel Biocare

News provided by

CAPITAL PRO-EGAUX INC.

Oct 02, 2012, 17:07 ET